Mclean
The Pharmaceutical Journal has launched a new initiative looking at the potential of genomic medicine to revolutionise patient care and the role that pharmacy should have in that change.
The #PJgenomics project aims to start a profession-wide conversation about genomic medicine, with a short survey launched on 12 January 2022 to gather data on what UK pharmacy professionals think about genomic medicine, the barriers they face and any educational needs.
The survey data will be used to inform future coverage about genomic medicine and will be published in The Pharmaceutical Journal in aggregate form. No personal data will be published.
In addition, The Pharmaceutical Journal is also launching a ‘call for papers’ on genomic medicine to gather as much experience, opinion and best practice as possible from pharmacy professionals on this topic.
If you have anything you would like to write about, or you would like to submit some ideas on what we should cover, click here for more information.
A Pharmaceutical Journal editorial published today says: “As part of the Royal Pharmaceutical Society, which is also planning support for pharmacy professionals in this area in 2022, we aim to ensure that the profession is open and ready for the exciting changes that are coming in the years ahead.”
Click here to complete the survey
